Your browser doesn't support javascript.
loading
PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking.
Lugnier, Claire; Al-Kuraishy, Hayder M; Rousseau, Eric.
Afiliação
  • Lugnier C; Directeur de Recherche 1 CNRS/université de Strasbourg, Institut de Physiologie, Faculté de Médecine, CRBS, UR3072: "Mitochondrie, stress oxydant et protection musculaire", 1 rue Eugène Boeckel, 67000 Strasbourg, France. Electronic address: claire.lugnier@unistra.fr.
  • Al-Kuraishy HM; Medical Faculty College of Medicine, Al-Mustansiriya University, P.O. Box 14132, Baghdad, Iraq.
  • Rousseau E; Department of Obstetrics and Gynecology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, and Centre de Recherche du CHUS, Sherbrooke, QC, Canada.
Biochem Pharmacol ; 185: 114431, 2021 03.
Article em En | MEDLINE | ID: mdl-33515531

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Fosfodiesterase 4 / Fumar Cigarros / Tratamento Farmacológico da COVID-19 / Pulmão / Pneumopatias Limite: Animals / Humans Idioma: En Revista: Biochem Pharmacol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Fosfodiesterase 4 / Fumar Cigarros / Tratamento Farmacológico da COVID-19 / Pulmão / Pneumopatias Limite: Animals / Humans Idioma: En Revista: Biochem Pharmacol Ano de publicação: 2021 Tipo de documento: Article